We are live on ! Find out more
TARA icon

Protara Therapeutics
TARA

15 hedge funds and large institutions have $1.96M invested in Protara Therapeutics in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

7% more funds holding

Funds holding: 14 → 15 (+1)

0.02% more ownership

Funds ownership: 0.58% → 0.6% (+0.02%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

13% less capital invested

Capital invested by funds: $2.25M → $1.96M (-$283K)

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.33%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
3
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$109K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$54.5K
3
WS
Wedbush Securities
California
+$19.9K
4
Citadel Advisors
Citadel Advisors
Florida
+$18.6K
5
Jane Street
Jane Street
New York
+$4.56K

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$64.4K
2
TSS
Two Sigma Securities
New York
-$26K
3
BlackRock
BlackRock
New York
-$14.1K
4
Mariner
Mariner
Kansas
-$5K
5
Morgan Stanley
Morgan Stanley
New York
-$4.38K
Name Holding Trade Value Shares
Change 		Change in
Stake
A
1
Abingworth
United Kingdom
$851K – – –
DM
2
Deerfield Management
New York
$510K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$292K +$109K +6,179 +54%
DVC
4
Deer VII & Co
New York
$132K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$64K +$54.5K +3,083 +381%
WS
6
Wedbush Securities
California
$43K +$19.9K +1,125 +76%
Vanguard Group
7
Vanguard Group
Pennsylvania
$37K -$64.4K -3,644 -62%
Citadel Advisors
8
Citadel Advisors
Florida
$17K +$18.6K +1,051 New
Northern Trust
9
Northern Trust
Illinois
$7K – – –
RJFSA
10
Raymond James Financial Services Advisors
Florida
$5K – – –
Jane Street
11
Jane Street
New York
$4K +$4.56K +258 New
BlackRock
12
BlackRock
New York
$2K -$14.1K -795 -85%
TSS
13
Two Sigma Securities
New York
– -$26K -1,270 Closed
Mariner
14
Mariner
Kansas
– -$5K -250 Closed
Morgan Stanley
15
Morgan Stanley
New York
– -$4.38K -248 -99%
FDCDDQ
16
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$1.01K -50 Closed
Bank of America
17
Bank of America
North Carolina
– +$442 +25 New
SPIA
18
Steward Partners Investment Advisory
New York
– +$884 +50 New

TARA Hedge Fund Activity: Q2 2019 in Review

15 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q2 2019, worth a combined $1.96M — down 13% from $2.25M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new TARA positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $109K. The largest seller was Vanguard Group, cutting an estimated $64.4K.

  • 15 institutional investors held Protara Therapeutics (TARA) as of Q2 2019, up from 14 in Q1 2019.
  • Funds reported $1.96M of Protara Therapeutics stock for Q2 2019, down 13% quarter-over-quarter.
  • 4 funds opened new Protara Therapeutics positions in Q2 2019 and 3 closed out, a net change of +1 holder.
  • The largest Protara Therapeutics buyer in Q2 2019 was Renaissance Technologies, an estimated $109K added.
  • The largest Protara Therapeutics seller in Q2 2019 was Vanguard Group, an estimated $64.4K sold.

Based on aggregated 13F filings for Q2 2019.